Neochem Bio Solutions IPO Details

SME

Neochem Bio Solutions IPO opens for subscription on 02 Dec 2025 and closes on 04 Dec 2025. The IPO will be listed on NSE with the tentative listing date set for 09 Dec 2025.

Neochem Bio Solutions IPO price band has been fixed at ₹93 – ₹98 per share.The face value is ₹10 per share with a lot size of 1200.

Neochem Bio Solutions IPO total issue size comprises 45,88,800 shares (aggregating up to ₹44.97 Cr.). This includes a fresh issue of 45,88,800 shares (aggregating up to ₹44.97 Cr.). Pre-issue shareholding stands at 1,25,31,953, which will increase to 1,71,20,753 post-issue.

Neochem Bio Solutions IPO carries a ₹2 (2.04%) GMP, reflecting investor sentiment.

Neochem Bio Solutions IPO Lot Size : Individual Minimum is 2 lots (2,400 shares) amounting to ₹235,200. Individual Maximum is 2 lots (2,400 shares) amounting to ₹235,200. SHNI Minimum is 3 lots (3,600 shares) amounting to ₹352,800. SHNI Maximum is 8 lots (9,600 shares) amounting to ₹940,800. BHNI Minimum is 9 lots (10,800 shares) amounting to ₹1,058,400.

The Lead Managers for Neochem Bio Solutions IPO are crucial for the offering's success. They are responsible for a wide range of tasks, including preparing the company for the public market, managing the regulatory filings, and marketing the IPO to potential investors. The lead manager for this offering is Vivro Financial Services Pvt Ltd. To assess their past performance and success in previous IPOs, you can view the Lead Manager Performance Summary report.

For SME (Small and Medium-sized Enterprise) IPOs, a Market Maker is appointed to ensure liquidity and stability for the stock once it is listed. They do this by continuously quoting bid and ask prices, ensuring there is a market for the shares. The appointed market maker for this IPO is Rikhav Securities. You can analyze their track record by checking the Market Maker Performance Summary report.

For detailed information, Refer to the Neochem Bio Solutions Limited RHP.

Neochem Bio Solutions IPO Details

Listing Price : ₹108 at a Premium of 10.2%

Open Date

02 Dec 2025

Close Date

04 Dec 2025

Listing Date

09 Dec 2025

Issue Price

₹93 - ₹98

Face Value

₹10 per share

Lot Size

1200

GMP

₹2 (2.04%)

Issue Type

IPO

Listing On

NSE

Type

Book Built Issue

Share holding pre issue

12531953

Share holding post issue

17120753

Total Issue Size

45,88,800 shares (aggregating up to ₹44.97 Cr.)

Fresh Issue

45,88,800 shares (aggregating up to ₹44.97 Cr.)

Offer for Sale

Neochem Bio Solutions IPO Subscription

Neochem Bio Solutions IPO Application Wise Breakup

Neochem Bio Solutions IPO Dates

02 Dec 2025
Opening dateOpen
04 Dec 2025
Closing dateClose
05 Dec 2025
Allotment Date Allotment
08 Dec 2025
Initiation of RefundsRefund
08 Dec 2025
Credit of SharesCredit
09 Dec 2025
Listing dateListing

Neochem Bio Solutions IPO Lot Size

Application	Lots	Shares	Amount
Individual Minimum	2	2400	₹235,200
Individual Maximum	2	2400	₹235,200
SHNI Minimum	3	3600	₹352,800
SHNI Maximum	8	9600	₹940,800
BHNI Minimum	9	10800	₹1,058,400

Neochem Bio Solutions IPO Reservation

Promoter Holding

Pre Issue:91.12%

Post Issue:66.7%

Promoter Names:

Swapnil Rameshbhai Makati, Hemangini Swapnil Dathia

Documents

› Neochem Bio Solutions IPO DRHP

› Neochem Bio Solutions IPO RHP

› Anchor Investors in Neochem Bio Solutions IPO

› Neochem Bio Solutions IPO BOA

Neochem Bio Solutions IPO Valuations

ROE:48.82%

ROCE:41.67%

DEBT/EQUITY:1.80

RONW:48.82%

PAT MARGIN:9.00%

PRICE TO BOOK VALUE:5.80

P/E Pre IPO:15.85

P/E Post IPO:15.3

Neochem Bio Solutions Financial Information

Period Ended	30 Sep 2025	31 Mar 2025	31 Mar 2024	31 Mar 2023
Assets	96.49	78.89	64.06	50.60
Total Income	47.18	86.15	62.01	48.79
Profit After Tax	5.48	7.75	1.80	1.07
EBITDA	8.59	13.11	5.99	4.23
NET Worth	32.24	19.75	12.00	8.05
Reserves and Surplus	19.70	13.08	5.33	2.63
Total Borrowing	38.54	35.62	33.32	26.24
Amount in ₹ Crore

About Neochem Bio Solutions IPO

Established in 2006, Neochem Bio Solutions Ltd. operates in the field of specialty performance chemicals, supplying products that play a crucial role across multiple industrial applications.

Its product portfolio serves a wide range of sectors, including textile and garment processing, home and personal care (HPC), institutional and industrial cleaning, water treatment, paints and coatings, paper and pulp, construction, rubber, and dyes and pigments.

Neochem Bio Solutions provides an extensive selection of textile and garment washing auxiliaries, covering pre-treatment, dyeing, finishing, printing, and coating requirements. These auxiliaries are compatible with various fabric types and garment substrates and are suitable for use across different processing machines.

The company’s manufacturing operations are carried out at its facility located in Saket Industrial Estate, Village Moraiya, Taluka Sanand, District Ahmedabad. The plant spans 6,763 square meters and has an installed production capacity of 22,000 metric tonnes per annum (MTPA).

Strength Of Neochem Bio Solutions IPO

Integrated and flexible manufacturing operations for sustainable formulations enabling customized supply.
Strong understanding of applied chemistries for diverse end-use industries.
Established long-standing relationships with customers across end-use industries.
Research and development (R&D) capabilities for development of innovative performance chemistries.
Established sales and distribution network.
Experienced Promoters with strong management team having domain knowledge.

Risk Of Neochem Bio Solutions IPO

We derive a substantial portion of our revenue from the textile industry. Consequently, any material decline in the performance of the textile sector, or our failure to sustain, grow, or efficiently manage our sales within this sector, may materially and adversely affect our business operations, financial condition and results of operations.
Our Company derives revenue from diversified customers. Our inability to acquire new customers or loss of all or a substantial portion of any of our major customers, for any reason and/or continued reduction of the business from them, could have a material adverse impact on our business, results of operations, cash flows and financial condition.
We do not maintain long-term contractual arrangements with the majority of our customers. As a result, the loss of one or more key customers, or any significant reduction in their demand for our products, could materially and adversely affect our business operations, financial condition, results of operations and cash flows.
Underutilization of the installed capacities at our Company may have an adverse impact on our growth and future profitability.
We derive a significant portion of our revenue from operations from domestic sales which exposes us to risks specific to Indian geographies and market.
We are required to adhere to quality standards in the manufacturing of our products. Our inability to comply with such parameters may result in termination or loss of business from our customers which, in turn, may have a material adverse effect on our business prospects and results of operations.
A significant increase in the cost of raw materials, particularly if not matched by a corresponding increase in product pricing or revenue, could materially and adversely affect our profit margins and overall financial performance. If we are unable to pass on these increased costs to our customers, it may result in reduced profitability and negatively impact our results of operations and financial condition.
We have not made any long-term supply arrangement or agreement with our suppliers. In an eventuality where our suppliers are unable to deliver us the required materials, at a competitive price, in a time-bound manner it may have a material adverse effect on our business operations and profitability.
Our manufacturing facility situated in Moraiya, Ahmedabad is critical for our business and any disturbance, slowdown or shutdown of our Moraiya manufacturing facility, may have an adverse impact on our business, results of operations and financial conditions.
Our operations can be adversely affected in case of industrial accidents at our manufacturing units. Further, any fire or mishap or accidents of such nature at the Company's facilities could lead to accident claims and damage and loss of property, inventory, raw materials, etc.